ArticleBMC cancer2018

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.

Maurizio Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.